The prognostic role of perirenal fat tissue in non-metastatic renal cell carcinoma
- PMID: 38856877
- DOI: 10.1007/s11604-024-01609-0
The prognostic role of perirenal fat tissue in non-metastatic renal cell carcinoma
Abstract
Purpose: The aim of this study was to evaluate the impact of perirenal fat volume and perirenal fat density on prognosis in surgically treated non-metastatic renal cell carcinomas (RCC).
Methods and materials: All consecutive patients who underwent partial or total nephrectomy surgery between March 2019 and December 2021 were assessed. Measurements of perirenal fat volume and perirenal fat density were performed on computed tomography (CT) images. The relationship between progression and perirenal fat parameters was evaluated using ROC analysis, Cox regression analysis, and Kaplan-Meier analysis.
Results: In the study population comprising 118 patients diagnosed with RCC (74.6% male, mean age of 59.1 ± 11.8 years), the median follow-up duration was 43 months (interquartile range: 33-51 months). Perirenal fat volume (AUC: 0.669, 95% CI 0.538-0.799, p = 0.011) and perirenal fat density (AUC: 0.680, 95% CI 0.558-0.803, p = 0.007) demonstrated acceptable discrimination performance in predicting progression. There was a significant association between high perirenal fat volume and high perirenal fat density with poor progression-free survival (HR: 1.007, 95% CI 1.003-1.011, p = 0.001 vs. HR: 1.084, 95% CI 1.033-1.137, p = 0.001; respectively).
Conclusion: High perirenal fat volume and high perirenal fat density are independent predictors for poor progression-free survival. Perirenal fat parameters, easily obtainable from preoperative CT images, may serve as potential tools in predicting the prognosis of non-metastatic RCC.
Keywords: Computed tomography; Perirenal fat; Progression; Renal cell carcinoma; Survival.
© 2024. The Author(s) under exclusive licence to Japan Radiological Society.
Similar articles
-
Prognostic value of preoperative radiographic perinephric fat features in renal cell carcinoma patients undergoing surgery.Asian J Surg. 2024 May;47(5):2188-2194. doi: 10.1016/j.asjsur.2024.02.048. Epub 2024 Feb 21. Asian J Surg. 2024. PMID: 38383186
-
High perirenal fat thickness predicts a poor progression-free survival in patients with localized clear cell renal cell carcinoma.Urol Oncol. 2018 Apr;36(4):157.e1-157.e6. doi: 10.1016/j.urolonc.2017.12.011. Epub 2018 Jan 4. Urol Oncol. 2018. PMID: 29307598
-
Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?Eur Urol. 2015 May;67(5):943-51. doi: 10.1016/j.eururo.2014.11.055. Epub 2015 Feb 13. Eur Urol. 2015. PMID: 25684695
-
Computed tomography features predicting aggressiveness of malignant parenchymal renal tumors suitable for partial nephrectomy.Minerva Urol Nephrol. 2021 Feb;73(1):17-31. doi: 10.23736/S2724-6051.20.04073-4. Epub 2020 Nov 17. Minerva Urol Nephrol. 2021. PMID: 33200903 Review.
-
Perirenal Fat and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.Kidney Blood Press Res. 2025;50(1):240-248. doi: 10.1159/000543989. Epub 2025 Mar 7. Kidney Blood Press Res. 2025. PMID: 40058346
Cited by
-
Response to letter to the editor from Dr. Muhammed Said Beşler: 'the accuracy of large language models in RANZCR's clinical radiology exam sample questions'.Jpn J Radiol. 2024 Sep;42(9):1081-1082. doi: 10.1007/s11604-024-01594-4. Epub 2024 May 24. Jpn J Radiol. 2024. PMID: 38789910 No abstract available.
-
Integrating AI in radiology: insights from GPT-generated reports and multimodal LLM performance on European Board of Radiology examinations.Jpn J Radiol. 2024 Sep;42(9):1083-1084. doi: 10.1007/s11604-024-01576-6. Epub 2024 Apr 22. Jpn J Radiol. 2024. PMID: 38647884 No abstract available.
-
The prognostic role of perinephric adipose tissue macrophages in localized clear cell renal cell carcinoma.World J Surg Oncol. 2025 May 31;23(1):212. doi: 10.1186/s12957-025-03861-8. World J Surg Oncol. 2025. PMID: 40450292 Free PMC article.
-
Response to Letter to the Editor from Muhammed Said Beşler et al.: "The Performance of the Multimodal Large Language Model GPT-4 on the European Board of Radiology Examination Sample Test".Jpn J Radiol. 2024 Aug;42(8):928. doi: 10.1007/s11604-024-01577-5. Epub 2024 May 2. Jpn J Radiol. 2024. PMID: 38696057 No abstract available.
References
-
- Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009. https://doi.org/10.1038/nrdp.2017.9 . - DOI - PubMed - PMC
-
- Padala SA, Barsouk A, Thandra KC, Saginala K, Mohammed A, Vakiti A, et al. Epidemiology of renal cell carcinoma. World J Oncol. 2020;11(3):79–87. https://doi.org/10.14740/wjon1279 . - DOI - PubMed - PMC
-
- Ciccarese C, Strusi A, Arduini D, Russo P, Palermo G, Foschi N, et al. Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario. Cancer Treat Rev. 2023;115:102528. https://doi.org/10.1016/j.ctrv.2023.102528 . - DOI - PubMed
-
- Dabestani S, Thorstenson A, Lindblad P, Harmenberg U, Ljungberg B, Lundstam S. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study. World J Urol. 2016;34(8):1081–6. https://doi.org/10.1007/s00345-016-1773-y . - DOI - PubMed
-
- Abou Elkassem AM, Lo SS, Gunn AJ, Shuch BM, Dewitt-Foy ME, Abouassaly R, et al. Role of imaging in renal cell carcinoma: a multidisciplinary perspective. Radiographics. 2021;41(5):1387–407. https://doi.org/10.1148/rg.2021200202 . - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical